Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A central role for JNK in obesity and insulin resistance.

Nature | Nov 21, 2002

http://www.ncbi.nlm.nih.gov/pubmed/12447443

Obesity is closely associated with insulin resistance and establishes the leading risk factor for type 2 diabetes mellitus, yet the molecular mechanisms of this association are poorly understood. The c-Jun amino-terminal kinases (JNKs) can interfere with insulin action in cultured cells and are activated by inflammatory cytokines and free fatty acids, molecules that have been implicated in the development of type 2 diabetes. Here we show that JNK activity is abnormally elevated in obesity. Furthermore, an absence of JNK1 results in decreased adiposity, significantly improved insulin sensitivity and enhanced insulin receptor signalling capacity in two different models of mouse obesity. Thus, JNK is a crucial mediator of obesity and insulin resistance and a potential target for therapeutics.

Pubmed ID: 12447443 RIS Download

Mesh terms: Adipose Tissue | Animals | Blood Glucose | Diabetes Mellitus, Type 2 | Diet | Disease Models, Animal | Gene Deletion | Homeostasis | Hyperinsulinism | Insulin | Insulin Receptor Substrate Proteins | Insulin Resistance | Lipid Metabolism | Mice | Mice, Knockout | Mice, Obese | Mitogen-Activated Protein Kinase 8 | Mitogen-Activated Protein Kinase 9 | Mitogen-Activated Protein Kinases | Obesity | Phosphoproteins | Phosphorylation | Receptor, Insulin | Signal Transduction

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.